Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von SERVIER
EUROPA-Studie (Perindopril) (60 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 32: EUROPA-Studie - Ausschlußkriterien Abb. 33: EUROPA-Studie - Charakteristika Abb. 34: EUROPA-Studie - Anamnese Aktuelles Bild - Abb. 35: EUROPA-Studie - Risikofaktoren Abb. 36: EUROPA-Studie - Medikation Abb. 37: EUROPA-Studie - Resultate Abb. 38: EUROPA-Studie - Primärer Endpunkt Zum letzten Bild
Abbildung 35: EUROPA-Studie - Risikofaktoren
Patients randomised in EUROPA trial involved: hypertensive patients, which presented 27 % of the study population, 11.8 % of patients had diabetes, 63.3 % were hypercholesterolemic and 15.4 % declared themselves as smokers. Again, a very balanced population was maintained between perindopril and placebo groups of patients.
 
EUROPA-Studie - Risikofaktoren
Vorheriges Bild Nächstes Bild   


Abbildung 35: EUROPA-Studie - Risikofaktoren
Patients randomised in EUROPA trial involved: hypertensive patients, which presented 27 % of the study population, 11.8 % of patients had diabetes, 63.3 % were hypercholesterolemic and 15.4 % declared themselves as smokers. Again, a very balanced population was maintained between perindopril and placebo groups of patients.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung